NASDAQ:RMTI - Rockwell Medical Stock Price, Forecast & News

Rockwell Medical trades on the NASDAQ under the ticker symbol "RMTI."

Rockwell Medical Inc (NASDAQ:RMTI) issued its earnings results on Monday, November, 11th. The company reported ($0.12) earnings per share for the quarter, beating analysts' consensus estimates of ($0.14) by $0.02. The company had revenue of $15.41 million for the quarter, compared to the consensus estimate of $15.40 million. Rockwell Medical had a negative return on equity of 139.38% and a negative net margin of 57.77%. View Rockwell Medical's Earnings History.

Rockwell Medical is scheduled to release their next quarterly earnings announcement on Thursday, March 12th 2020. View Earnings Estimates for Rockwell Medical.

4 brokers have issued twelve-month target prices for Rockwell Medical's shares. Their forecasts range from $6.00 to $11.00. On average, they anticipate Rockwell Medical's stock price to reach $9.33 in the next year. This suggests a possible upside of 221.8% from the stock's current price. View Analyst Price Targets for Rockwell Medical.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rockwell Medical in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Rockwell Medical.

Press coverage about RMTI stock has been trending very positive recently, InfoTrie Sentiment reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Rockwell Medical earned a news impact score of 3.5 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 4.0 out of 10, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days. View News Stories for Rockwell Medical.

Some companies that are related to Rockwell Medical include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), IDEXX Laboratories (IDXX), Teleflex (TFX), Steris (STE), Hologic (HOLX) and Varian Medical Systems (VAR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Rockwell Medical investors own include Immunomedics (IMMU), JinkoSolar (JKS), Seattle Genetics (SGEN), Agile Therapeutics (AGRX), Eyepoint Pharmaceuticals (EYPT), AcelRx Pharmaceuticals (ACRX), Iovance Biotherapeutics (IOVA), ImmunoGen (IMGN), Portola Pharmaceuticals (PTLA) and Bristol-Myers Squibb (BMY).

Rockwell Medical's stock is owned by a variety of of institutional and retail investors. Top institutional investors include State Street Corp (1.63%), Perkins Capital Management Inc. (1.16%), SkyOak Wealt LLC (0.39%), Bank of New York Mellon Corp (0.34%), Perritt Capital Management Inc. (0.14%) and UBS Group AG (0.14%). Company insiders that own Rockwell Medical stock include Angus W Smith, David S Richmond and Stuart M Paul. View Institutional Ownership Trends for Rockwell Medical.

RMTI stock was sold by a variety of institutional investors in the last quarter, including Perkins Capital Management Inc., State Street Corp, Bank of America Corp DE, Perritt Capital Management Inc., Bank of New York Mellon Corp, Citigroup Inc. and Raymond James & Associates. View Insider Buying and Selling for Rockwell Medical.

RMTI stock was purchased by a variety of institutional investors in the last quarter, including SkyOak Wealt LLC, Banco Bilbao Vizcaya Argentaria S.A., Renaissance Technologies LLC, UBS Group AG, Virtu Financial LLC, California Public Employees Retirement System, SG Americas Securities LLC and Prudential Financial Inc.. Company insiders that have bought Rockwell Medical stock in the last two years include Angus W Smith, David S Richmond and Stuart M Paul. View Insider Buying and Selling for Rockwell Medical.

Shares of RMTI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of RMTI stock can currently be purchased for approximately $2.90.

Rockwell Medical has a market capitalization of $185.48 million and generates $63.39 million in revenue each year. The company earns $-32,130,000.00 in net income (profit) each year or ($0.47) on an earnings per share basis. Rockwell Medical employs 269 workers across the globe.View Additional Information About Rockwell Medical.

The official website for Rockwell Medical is http://www.rockwellmed.com/.

Rockwell Medical's mailing address is 411 HACKENSACK AVENUE SUITE 501, HACKENSACK NJ, 07601. The company can be reached via phone at 248-960-9009 or via email at [email protected]